Healthpeak Properties, Inc. (NYSE:DOC) Quarterly Earnings Preview

Healthpeak Properties, Inc. (NYSE:DOC) Quarterly Earnings Preview

DOC
Neutral
Market
Healthpeak Properties, Inc. (NYSE:DOC) Quarterly Earnings Preview

Summary

Healthpeak Properties, Inc. (NYSE:DOC) Quarterly Earnings Preview

Healthpeak Properties, Inc. (NYSE:DOC) is expected to report an EPS of $0.46, mirroring its previous quarter's FFO per share. Projected revenue for the quarter stands at approximately $694 million, a slight increase of 0.3% year-over-year. The company's financial health is indicated by a P/E ratio of 47.57 and a debt-to-equity ratio of 1.12.

Healthpeak Properties, Inc. (NYSE:DOC) is a real estate investment trust (REIT) that specializes in healthcare sector properties, including senior housing, life science, and medical office buildings. As a significant entity in the healthcare real estate market, Healthpeak stands in competition with other REITs such as Welltower and Ventas.

On July 24, 2025, Healthpeak is slated to unveil its quarterly earnings, with analysts forecasting the company to announce earnings per share (EPS) of $0.46. This forecast aligns with the company's previous quarter's funds from operations (FFO) per share, which was also 46 cents. The anticipated revenue for this period is around $694 million, indicating a modest growth of 0.3% from the preceding year.

The company's performance benefits from increased healthcare expenditure and an aging demographic, which bolster demand for laboratory and senior care services. These elements are expected to drive year-over-year growth in revenues and FFO per share. Nonetheless, escalating interest expenses could mitigate these gains, presenting a challenge for Healthpeak.

Key financial metrics shed light on Healthpeak's valuation and fiscal health. The company's price-to-earnings (P/E) ratio stands at 47.57, demonstrating the amount investors are prepared to pay per dollar of earnings. Its price-to-sales ratio is 4.72, indicating the company's market value in relation to its revenue. Furthermore, the enterprise value to sales ratio is 7.98, illustrating the company's total valuation compared to its sales.

Healthpeak's debt-to-equity ratio is 1.12, underscoring its financial leverage. This ratio elucidates the extent of debt used by the company to finance its assets relative to equity. Moreover, the current ratio of 1.10 signifies Healthpeak's capability to fulfill its short-term liabilities with its short-term assets, an essential aspect for investors evaluating the company's financial stability and growth prospects.

Tags

DOC
stock
market
finance